Previous close | 85.00 |
Open | 85.00 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 85.00 |
Expiry date | 2025-03-21 |
Day's range | 85.00 - 85.00 |
Contract range | N/A |
Volume | |
Open interest | N/A |
AbbVie (ABBV) closed the most recent trading day at $170.46, moving +0.61% from the previous trading session.
Eli Lilly's (LLY) CFO Anat Ashkenazi resigns. CHMP recommends the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Tagrisso.
Data from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective response rate of almost 52% in certain heavily pre-treated patients with ovarian cancer.